Compare · SBRA vs VTR
SBRA vs VTR
Side-by-side comparison of Sabra Health Care REIT Inc. (SBRA) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SBRA and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $47.89B, about 8.9x SBRA ($5.37B).
- Over the past year, SBRA is up 12.9% and VTR is up 36.2% - VTR leads by 23.3 points.
- SBRA has been more active in the news (8 items in the past 4 weeks vs 6 for VTR).
- Both have 25 recent analyst ratings on file.
- Company
- Sabra Health Care REIT Inc.
- Ventas Inc.
- Price
- $21.04+0.62%
- $93.38+1.21%
- Market cap
- $5.37B
- $47.89B
- 1M return
- +5.89%
- +1.79%
- 1Y return
- +12.94%
- +36.21%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 8
- 6
- Recent ratings
- 25
- 25
Sabra Health Care REIT Inc.
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest SBRA
- Sabra Health Care REIT upgraded by Raymond James
- SEC Form 10-Q filed by Sabra Health Care REIT Inc.
- Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
- Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
- Sabra Health Care REIT Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Sabra Issues Business Update and Increases Full-Year 2026 Guidance
- Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Sabra Health Care REIT downgraded by Truist
- Barclays initiated coverage on Sabra Health Care REIT with a new price target
Latest VTR
- EVP OM&R-Ventas/Pres&CEO-LHS Wattula Andy was granted 15,008 shares (SEC Form 4)
- SEC Form 3 filed by new insider Wattula Andy
- SEC Form 10-Q filed by Ventas Inc.
- Ventas Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ventas Reports 2026 Second Quarter Results
- Amendment: SEC Form SCHEDULE 13G/A filed by Ventas Inc.
- Director Smith Maurice S was granted 128 shares, increasing direct ownership by 0.41% to 31,311 units (SEC Form 4)
- Director Embler Michael J was granted 72 shares, increasing direct ownership by 0.37% to 19,274 units (SEC Form 4)
- Director Nader Marguerite M was granted 72 shares, increasing direct ownership by 0.31% to 23,544 units (SEC Form 4)
- Director Roy Sumit was granted 119 shares, increasing direct ownership by 0.48% to 24,872 units (SEC Form 4)